Abstract

Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2019 - Volume 23, Number 6

Page(s): 492

Download in electronic PDF format for $75
  • Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1) Page 1

Abstract

A formulation for preparing Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1). Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • tadalafil
  • formulation
  • erectile dysfunction
  • benign prostatic hyperplasia
  • pulmonary arterial hypertension
  • female sexual dysfunction
  • phosphodiesterase type 5
  • PDE5 inhibitor
  • cyclic guanosine monophosphate
  • CMP

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • UROLOGY/URINARY TRACT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2019
Pg. 492
Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
Author(s): Allen Loyd V Jr
Jan/Feb 2013
Pg. 24-27
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Author(s): Wung Deanna
Jan/Feb 2021
Pg. 18-23
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
Author(s): McKettrick Greg, Yoch Doug
May/Jun 2019
Pg. 236
Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2007
Pg. 122-124
Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes
Author(s): Fields Shannon W
Mar/Apr 1999
Pg. 85-87
Complementary Medical Approaches to Benign Prostatic Hyperplasia
Author(s): Meletis Chris D
Mar/Apr 2021
Pg. 94-98
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
Author(s): McKettrick Greg, Yoch Doug
Mar/Apr 2021
Pg. 144
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 513
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 411
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 496
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions
Author(s): Allen Loyd V Jr
Jan/Feb 2023
Pg. 53
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Author(s): Allen Loyd V Jr
Jul/Aug 2019
Pg. 314
Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2022
Pg. 56
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 231-235
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.
Author(s): Trissel Lawrence A, Zhang Yanping
Nov/Dec 2006
Pg. 405-408
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals
Author(s): Davidson Gigi S
Mar/Apr 2010
Pg. 105-107
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Author(s): Williams LaVonn A
Jul/Aug 2006
Pg. 306
Sildenafil Citrate 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr